Fig. 1From: Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocolDiagram of anticipated updates of the living systematic review. Updates will increase the quantity and quality of evidence to refine conclusionsBack to article page